CE Activities
ManagedCareCGM.com Presents: Continuous Glucose Monitoring in Managed Care: Emerging Evidence, Quality Trends, and Policy Implications
August 11, 2026Population Health CE Activities
Intended Audience: This activity is designed to meet the education needs of managed are pharmacy directors, registered nurses, clinical pharmacists, quality directors and medical directors.
Credit Available: Up to 1.5 credit hours available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)
Expiration Date: January 31, 2028
Click Here to Begin
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe evolving guideline recommendations for CGM across diabetes populations
- Evaluate clinical, real-world, and economic evidence supporting CGM use
- Assess implications of CGM for HEDIS/Stars performance, coverage decisions, and population health strategies
Expert Faculty
Hannah Berg, PharmD
Associate Director, PDL Strategy
UnitedHealthcare
Jamie Chan, PharmD
President/CEO
Elevare Healthcare Consulting, LLC
Charlie Dragovich
Principal
Stractical Solutions LLC
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
Co-Director of Endocrine Disorders in Pregnancy
Director of Education and Training in Diabetes Technology
Cleveland Clinic Endocrinology & Metabolism Institute
Jaime Murillo, MD
SVP, CMO, Medical Affairs
UnitedHealthcare
This continuing education activity is supported by an independent educational grant from Dexcom Medical Affairs.
PayerTalkCE™ Presents: Diabetes Quality Management–Trends and Opportunities for Continuous Glucose Monitoring in Managed Care Pharmacy
June 3, 2024Population Health CE Activities
Intended Audience: This activity is designed to meet the education needs of managed are pharmacy directors, registered nurses, clinical pharmacists, quality directors and medical directors.
Credit Available: Up to 1.0 credit hour available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)
Expiration Date: December 31, 2025
CE Expired – Click Here to Review
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe recent updates to HEDIS measures in diabetes care, including opportunities associated with glucose management indicator (GMI) and an increased focus on equity
- Describe the synergistic impact of CGM and GLP-1 agonists
- Outline health plan best practices and strategies for streamlined coverage, access, and value of CGM
Expert Faculty
Clinical Pharmacist, Medicare Stars & Clinical Quality
Optum Rx
This continuing education activity is supported by an independent educational grant from Dexcom, Inc. Medical Affairs.
- 1
- 1-2 of 2 results
Sign Up To Stay Current On The Latest Coverage
Updates, Recent News, And Resources
ManagedCareCGM.com Presents: Continuous Glucose Monitoring in Managed Care: Emerging Evidence, Quality Trends, and Policy Implications
Intended Audience: This activity is designed to meet the education needs of managed are pharmacy directors, registered nurses, clinical pharmacists, quality directors and medical directors.
Credit Available: Up to 1.5 credit hours available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)
Expiration Date: January 31, 2028
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe evolving guideline recommendations for CGM across diabetes populations
- Evaluate clinical, real-world, and economic evidence supporting CGM use
- Assess implications of CGM for HEDIS/Stars performance, coverage decisions, and population health strategies
Expert Faculty
Hannah Berg, PharmD
Associate Director, PDL Strategy
UnitedHealthcare
Jamie Chan, PharmD
President/CEO
Elevare Healthcare Consulting, LLC
Charlie Dragovich
Principal
Stractical Solutions LLC
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
Co-Director of Endocrine Disorders in Pregnancy
Director of Education and Training in Diabetes Technology
Cleveland Clinic Endocrinology & Metabolism Institute
Jaime Murillo, MD
SVP, CMO, Medical Affairs
UnitedHealthcare
This continuing education activity is supported by an independent educational grant from Dexcom Medical Affairs.
PayerTalkCE™ Presents: Diabetes Quality Management–Trends and Opportunities for Continuous Glucose Monitoring in Managed Care Pharmacy
June 3, 2024Population Health CE Activities
Intended Audience: This activity is designed to meet the education needs of managed are pharmacy directors, registered nurses, clinical pharmacists, quality directors and medical directors.
Credit Available: Up to 1.0 credit hour available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)
Expiration Date: December 31, 2025
CE Expired – Click Here to Review
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe recent updates to HEDIS measures in diabetes care, including opportunities associated with glucose management indicator (GMI) and an increased focus on equity
- Describe the synergistic impact of CGM and GLP-1 agonists
- Outline health plan best practices and strategies for streamlined coverage, access, and value of CGM
Expert Faculty
Clinical Pharmacist, Medicare Stars & Clinical Quality
Optum Rx
This continuing education activity is supported by an independent educational grant from Dexcom, Inc. Medical Affairs.
- 1
- 1-2 of 2 results
PayerTalkCE™ Presents: Diabetes Quality Management–Trends and Opportunities for Continuous Glucose Monitoring in Managed Care Pharmacy
Intended Audience: This activity is designed to meet the education needs of managed are pharmacy directors, registered nurses, clinical pharmacists, quality directors and medical directors.
Credit Available: Up to 1.0 credit hour available for nurses (ANCC), pharmacists (ACPE), and physicians (AMA PRA Category 1 Credit™)
Expiration Date: December 31, 2025
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe recent updates to HEDIS measures in diabetes care, including opportunities associated with glucose management indicator (GMI) and an increased focus on equity
- Describe the synergistic impact of CGM and GLP-1 agonists
- Outline health plan best practices and strategies for streamlined coverage, access, and value of CGM
Expert Faculty
Clinical Pharmacist, Medicare Stars & Clinical Quality
Optum Rx
This continuing education activity is supported by an independent educational grant from Dexcom, Inc. Medical Affairs.
- 1
- 1-2 of 2 results